PlainRecalls
FDA Drug Moderate Class II Ongoing

Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box).

Reported: March 26, 2025 Initiated: February 27, 2025 #D-0286-2025

Product Description

Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box).

Reason for Recall

Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Details

Recalling Firm
Amgen, Inc.
Units Affected
258,750 Vials
Distribution
Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy/San Marino, Netherlands, Poland, Spain/Andorra, Sweden, Finland, Switzerland/Liechtenstein, United Kingdom of Great Britain and Northern Ireland, Ireland, Denmark, Canada, Hong Kong, Philippines, Israel, Malaysia, Saudi Arabia, Gibraltar.
Location
Thousand Oaks, CA

Frequently Asked Questions

What product was recalled?
Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box).. Recalled by Amgen, Inc.. Units affected: 258,750 Vials.
Why was this product recalled?
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2025. Severity: Moderate. Recall number: D-0286-2025.